1. Home
  2. CSTL vs CARE Comparison

CSTL vs CARE Comparison

Compare CSTL & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$34.49

Market Cap

722.8M

Sector

Health Care

ML Signal

HOLD

Logo Carter Bankshares Inc.

CARE

Carter Bankshares Inc.

HOLD

Current Price

$30.71

Market Cap

723.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTL
CARE
Founded
2007
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
722.8M
723.5M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
CSTL
CARE
Price
$34.49
$30.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$45.50
$25.00
AVG Volume (30 Days)
275.5K
196.2K
Earning Date
05-06-2026
04-23-2026
Dividend Yield
N/A
0.40%
EPS Growth
N/A
30.19
EPS
N/A
5.18
Revenue
$344,229,000.00
$20,315,000.00
Revenue This Year
$2.42
$12.50
Revenue Next Year
$12.69
$11.82
P/E Ratio
N/A
$5.94
Revenue Growth
3.66
4.65
52 Week Low
$17.72
$16.78
52 Week High
$44.28
$36.06

Technical Indicators

Market Signals
Indicator
CSTL
CARE
Relative Strength Index (RSI) 58.21 40.91
Support Level $22.88 $30.41
Resistance Level $42.03 $32.29
Average True Range (ATR) 1.44 0.79
MACD 0.01 -0.04
Stochastic Oscillator 57.86 37.83

Price Performance

Historical Comparison
CSTL
CARE

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

Share on Social Networks: